KESHAV
MYR 1,083.34
1,000+ terjualFarmasi fizikal Hong Kong dengan jaminan produk tulen 100%
Anamorelin, a prescription medicine targeting the ghrelin receptor GHS-R1a, was approved in Japan in January 2021 and launched in April of the same year. Use it only as directed by a physician.
10000 in stock
Indicated for adults with cancer cachexia associated with malignant tumors such as non-small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer.
Anamorelin Mekanisme Tindakan Mekanisme Tindakan ，
Please use this product according to the package instructions, pharmacist review, or your doctor’s advice. Do not adjust the dose on your own.
EMA Refused - No
Indicated for adults with cancer cachexia associated with malignant tumors such as non-small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer.
Please use this product according to the package instructions, pharmacist review, or your doctor’s advice. Do not adjust the dose on your own.
EMA Refused - No
Indikasi
Indicated for adults with cancer cachexia associated with malignant tumors such as non-small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer.
Mekanisme Tindakan
Anamorelin Mekanisme Tindakan Mekanisme Tindakan ，
Dos dan Cara Penggunaan
Please use this product according to the package instructions, pharmacist review, or your doctor’s advice. Do not adjust the dose on your own.
Langkah Berjaga-jaga
EMA Refused - No
